-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on DexCom, Raises Price Target to $95

Benzinga·07/31/2026 13:49:55
Listen to the news
Stifel analyst Jonathan Block maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $95.